Stock Track | ALI HEALTH Plummets 5.10% Intraday After Goldman Sachs Cuts Target Price on AI and Drug Investment Concerns

Stock Track

04/09

ALI HEALTH's stock plummeted 5.10% during intraday trading on Thursday, reflecting significant selling pressure.

The decline followed a report from Goldman Sachs which lowered its target price for ALI HEALTH from HK$5.20 to HK$4.80 while maintaining a "Neutral" rating. The adjustment reflects the bank's concerns that increased investments in artificial intelligence (AI) and pharmaceutical categories will negatively impact the company's profitability in the near term.

Goldman Sachs anticipates a slight profit contraction in the second half of the year, reversing the profit expansion seen in the first half. This outlook is primarily attributed to higher spending on AI initiatives and increased discounts on proprietary drugs offered in response to competitive pressures within the market.

免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。

热议股票

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.itiger.com/hans/news/1141985297"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1141985297\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1141985297?lang=zh_CN&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-04-09 15:53","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1141985297","market":"hk","top_or_hot":-1,"title":"Stock Track | ALI HEALTH Plummets 5.10% Intraday After Goldman Sachs Cuts Target Price on AI and Drug Investment Concerns","media":"Stock Track","content":"<p>ALI HEALTH's stock plummeted 5.10% during intraday trading on Thursday, reflecting significant selling pressure.</p><p>The decline followed a report from Goldman Sachs which lowered its target price for ALI HEALTH from HK$5.20 to HK$4.80 while maintaining a \"Neutral\" rating. The adjustment reflects the bank's concerns that increased investments in artificial intelligence (AI) and pharmaceutical categories will negatively impact the company's profitability in the near term.</p><p>Goldman Sachs anticipates a slight profit contraction in the second half of the year, reversing the profit expansion seen in the first half. This outlook is primarily attributed to higher spending on AI initiatives and increased discounts on proprietary drugs offered in response to competitive pressures within the market.</p>","source":"ai_movement_en","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Stock Track | ALI HEALTH Plummets 5.10% Intraday After Goldman Sachs Cuts Target Price on AI and Drug Investment Concerns</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nStock Track | ALI HEALTH Plummets 5.10% Intraday After Goldman Sachs Cuts Target Price on AI and Drug Investment Concerns\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1086803395\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Stock Track </p>\n<p class=\"h-time\">2026-04-09 15:53</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>ALI HEALTH's stock plummeted 5.10% during intraday trading on Thursday, reflecting significant selling pressure.</p><p>The decline followed a report from Goldman Sachs which lowered its target price for ALI HEALTH from HK$5.20 to HK$4.80 while maintaining a \"Neutral\" rating. The adjustment reflects the bank's concerns that increased investments in artificial intelligence (AI) and pharmaceutical categories will negatively impact the company's profitability in the near term.</p><p>Goldman Sachs anticipates a slight profit contraction in the second half of the year, reversing the profit expansion seen in the first half. This outlook is primarily attributed to higher spending on AI initiatives and increased discounts on proprietary drugs offered in response to competitive pressures within the market.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"00241","symbol_name":"阿里健康","start_time":0,"source_url":"","article_id":"1141985297","we_media_id":"1086803395","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1141985297","pubTimestamp":1775721208,"columns":[],"sourceInfo":{"source_id":"ai_movement_en","name":"Stock Track"},"weMediaInfo":{"media_name":"Stock Track","introduction":"Track stock‘s movements and relevant news","home_visible":1,"id":"1086803395","head_image":"https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390"},"summary":"ALI HEALTH's stock plummeted 5.10% during intraday trading on Thursday, reflecting significant selling pressure.The decline followed a report from Goldman Sachs which lowered its target price for ALI...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"00241":"阿里健康"},"translate_title":"个股赛道|阿里健康盘中暴跌5.10%高盛因AI和药物投资担忧下调目标价","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"00241":1},"content_text":"ALI HEALTH's stock plummeted 5.10% during intraday trading on Thursday, reflecting significant selling pressure.The decline followed a report from Goldman Sachs which lowered its target price for ALI HEALTH from HK$5.20 to HK$4.80 while maintaining a \"Neutral\" rating. The adjustment reflects the bank's concerns that increased investments in artificial intelligence (AI) and pharmaceutical categories will negatively impact the company's profitability in the near term.Goldman Sachs anticipates a slight profit contraction in the second half of the year, reversing the profit expansion seen in the first half. This outlook is primarily attributed to higher spending on AI initiatives and increased discounts on proprietary drugs offered in response to competitive pressures within the market.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"-1","news_tag":"movement","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":1,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"}}}